The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma

被引:3
|
作者
Zhang, Lishuo [1 ]
Di, Longjiang [2 ]
Liu, Jinhui [3 ]
Lei, Xianli [4 ]
Gu, Maoli [1 ]
Zhang, Wenjing [3 ]
Wang, Yufu [3 ]
机构
[1] Harbin Med Univ, Dept Urol, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China
[2] Southern Med Univ, Coll Basic Med, Guangzhou, Guangdong, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Harbin, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
clear cell renal cell carcinoma; long non-coding RNA; cuproptosis; prognosis; immunotherapy; CLASSIFICATION;
D O I
10.3389/fgene.2023.1039813
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with tumorigenesis. However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (ccRCC) in the context of immunotherapy remains unknown. The aim of this study was to investigate the correlation between cuproptosis-related long non-coding RNA (lncRNA) and ccRCC in terms of immunity as well as prognosis. Clinical information on lncRNAs associated with differences in cuproptosis genes in ccRCC and normal tissues was collected from The Cancer Genome Atlas (TCGA) dataset. Univariate Cox regression was used to screen lncRNAs. A total of 11 lncRNAs closely associated with cuproptosis were further screened and established using the least absolute shrinkage and selection operator (LASSO) algorithm and multivariate Cox regression, and the samples were randomly divided into training and test groups. A risk prognostic model was constructed using the training group, and the model was validated using the test group. We investigated the predictive ability of the prognostic risk model in terms of clinical prognosis, tumor mutation, immune escape, immunotherapy, tumor microenvironment, immune infiltration levels, and tumor drug treatment of ccRCC. Using the median risk score, patients were divided into low and high-risk groups. Kaplan-Meier curves showed that the overall survival (OS) of patients in the high-risk group was significantly worse than low-risk group (p < 0.001). Receiver operating characteristic (ROC) curves further validated the reliability of our model. The model consistently and accurately predicted prognosis at 1, 3, and 5 years, with an AUC above 0.7. Tumor cell genes generally precede morphological abnormalities; therefore, the model we constructed can effectively compensate for the traditional method of evaluating the prognosis of patients with renal cancer, and our model was also clinically meaningful in predicting ccRCC staging. In addition, lower model risk scores determined by mutational load indicated a good chance of survival. The high-risk group had greater recruitment of immune cells, while the anti-immune checkpoint immunotherapy was less efficacious overall than that of the low-risk group. Tumor and immune-related pathways were enriched, and anti-tumor agents were selected to improve the survival of ccRCC. This prognostic risk model is based on the levels of cuproptosis-associated lncRNAs and provides a new perspective in the clinical assessment and precise treatment of ccRCC.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
    Liu, Gang
    Li, Feifei
    Ge, Yuntian
    Shi, Yaxing
    Ren, Fang
    Zhu, Liancheng
    JOURNAL OF CANCER, 2023, 14 (17): : 3335 - 3350
  • [22] Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
    Guo, Tuanjie
    Zhang, Jian
    Yuan, Zhihao
    Tang, Heting
    Wang, Tao
    Wang, Xiang
    Chen, Siteng
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [23] A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma
    Zhang, Wei
    Wang, Han
    Wang, Wei
    Xue, Haoqiang
    Qiao, Maolin
    Song, Liying
    Wang, Shuang
    Ren, Zhaoyu
    Ma, Zhifang
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [24] Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma
    Chen, Yongquan
    Hu, Weijing
    Wei, Xin
    Zhang, Lin
    Shao, Yuan
    Tian, Jinming
    Wang, Dongwen
    Wu, Bo
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (04) : 622 - +
  • [25] A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Zhou, Hui
    Zeng, Jin
    Tang, Kun
    Ye, Zhangqun
    JOURNAL OF CANCER, 2020, 11 (14): : 4274 - 4283
  • [26] Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
    Wang, Hu
    Yang, Zhan
    He, Xingyu
    Guo, Fengran
    Sun, Hao
    Xu, Sen
    Xu, Chao
    Wang, Zhu
    Wen, Hongzhuang
    Teng, Zhihai
    Wang, Yaxuan
    Han, Zhenwei
    BMC CANCER, 2023, 23 (01)
  • [27] Cuproptosis related gene PDHB is identified as a biomarker inversely associated with the progression of clear cell renal cell carcinoma
    Hu Wang
    Zhan Yang
    Xingyu He
    Fengran Guo
    Hao Sun
    Sen Xu
    Chao Xu
    Zhu Wang
    Hongzhuang Wen
    Zhihai Teng
    Yaxuan Wang
    Zhenwei Han
    BMC Cancer, 23
  • [28] Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma
    Liu, Huibin
    Chen, Peng
    Jiang, Chunyang
    Han, Jing
    Zhao, Bing
    Ma, Yujiao
    Mardan, Mahmut
    MEDICINE, 2016, 95 (02)
  • [29] A novel inflammation-associated prognostic signature for clear cell renal cell carcinoma
    Liu, Gangcheng
    Xiong, Donglan
    Che, Zhifei
    Chen, Hualei
    Jin, Wenyi
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [30] Characterization of cuproptosis signature in clear cell renal cell carcinoma by single cell and spatial transcriptome analysis
    Zou, Xiaohong
    Liu, Xiaoqing
    Wang, Huiting
    Li, Zhenhua
    Zhou, Chen
    DISCOVER ONCOLOGY, 2024, 15 (01)